Ceribell, Inc., a commercial-stage medical technology company focused on transforming the detection and management of patients with serious neurological conditions, announced the publication of results from a new multi-center retrospective study of patient outcomes following use of the Ceribell system compared to conventional electroencephalography ("EEG").
A patient in Cincinnati has become the first in the United States to receive an innovative system that enables remote monitoring of his heart and congestion status, as well as self-adjustment of diuretics.
VisionAir Solutions (VAS), the small company with a big idea for better therapeutic solutions, proudly announces a significant milestone of custom developing over 600 patient-specific airway stents using our AI VisionAir 3D Stent Software—helping save the lives of these patients.
NextStep Arthropedix, a growing orthopedic implants and procedures company, announced the launch of TheRay™ Collared and Collarless Hip System.
Bedal International, a Belgian based medical device company delivering next generation catheter securement solutions, announces the successful closing of a $11 million funding round. The investment will be used to support the company's ongoing global growth. Bedal has offices in Belgium (EU) and in Anaheim, CA.
Stratasys Ltd. (NASDAQ: SSYS), announced the launch of the groundbreaking DentaJet™ XL, the latest innovation in dental 3D printing technology. This new high-speed 3D printer is the latest addition to the DentaJet series, designed to further improve dental lab productivity and reduce costs with its larger resin cartridges, large print tray, Super High-Speed mode, and minimal post processing workflow.
New4med GmbH, a German startup focused on innovative spinal treatments, announces the successful European market launch of its novel Basivertebral Nerve Ablation (BVNA) therapy.
DP Technology, an "AI for Science" paradigm-driven company, today announced the nomination of DPT0416, a novel CNS penetrable small molecule targeting Lp-PLA2, as a preclinical candidate for the treatment of Alzheimer's disease (AD).
Carestream Health announced the addition of new enhancements to its ImageView Software and DRX-Evolution Plus System, marking the latest improvements to its line of innovative, industry-leading imaging solutions.
American Regent announces the launch and availability of Sodium Phosphates Injection, USP, which is FDA-approved and therapeutically equivalent to Sodium Phosphates.